Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

Boston Scientific (NYSE:BSX) today announced a definitive agreement to acquire cardiovascular disease treatment device maker ...

Boston Scientific Corp (NYSE:BSX) announced on Thursday that it has agreed to acquire medical technology company Penumbra ...

Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...

Boston Scientific Corporation and Penumbra, Inc. announced that the companies have entered into a definitive agreement under ...

Boston Scientific Corporation (NYSE: BSX) and Penumbra, Inc., (NYSE: PEN) today announced the companies have entered into a ...

Boston Scientific to acquire thrombectomy firm Penumbra for $14.5bn, expanding its cardiovascular portfolio as deal reshapes ...

In a bold move to expand its cardiovascular portfolio, Boston Scientific Corporation has announced its acquisition of Penumbra, Inc. This strategic partnership, valued at approximately $14.5 billion, ...

Jan 15 (Reuters) - Boston Scientific said on Thursday it will buy medtech firm Penumbra in a deal valued at about $14.5 ...

Boston Scientific enters agreement to acquire Penumbra for $14.5 billion: Marlborough, Massachusetts Friday, January 16, 2026, 14:30 Hrs [IST] Boston Scientific Corporation and Pe ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $353.86, a high estimate of $388.00, and a low estimate of $275.00. Marking an increase of 10.32%, the ...

Boston Scientific Corp (NYSE:BSX) said on Thursday it has reached a deal to acquire medical technology firm Penumbra ...